ABBVIE INC
- Country
- United States
- Type
- Beneficiary
- Website
- www.abbvie.com
- Grants received
- 27
Funding record
- 27 grants on record
- 2016–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
23 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- BAYER AKTIENGESELLSCHAFT
- JANSSEN PHARMACEUTICA NV
- ASTRAZENECA AB
- NOVARTIS PHARMA AG
- BOEHRINGER INGELHEIM INTERNATIONALGMBH
- BRISTOL-MYERS SQUIBB COMPANY CORP
- ELI LILLY AND COMPANY LTD
- MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
Calls from this organisation
No published calls from this organisation.
Grants received
- Research in Europe and Diversity Inclusion
- Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT)
- Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
- GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD
- FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem
- Optimal treatment for patients with solid tumours in Europe through Artificial intelligence
- Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States
- Real World Handling of Protein Drugs - Exploration, Evaluation and Education
- Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
- HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS
- H2O Health Outcomes Observatory
- Corona Accelerated R&D in Europe
- PharmaLedger
- EU Patient- cEntric clinicAl tRial pLatform
- Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.